Literature DB >> 22566222

Structure and physicochemical characterisation of heparin.

Barbara Mulloy1.   

Abstract

Heparin is a member of the heparan sulphate family of glycosaminoglycans, a linear polysaccharide with a complex sequence resulting from the action of post-polymerisation enzymes on a regular repeating disaccharide background. Its overall conformation is rod-like in solution as well as in the solid state, but the conformational fluctuations of iduronate residues give rise to considerable internal motion and variation in local three-dimensional structure. Structure/function relationships and their relation to sequence are still the subject of argument, but new methodologies to tackle the subject are emerging. Heparin as a therapeutic agent and as the object of research may be characterised by numerous physico-chemical techniques. These include chromatographic methods for measurement of molecular weight; a variety of spectroscopic techniques; separation methods for whole polysaccharides, as well as for oligo- and monosaccharides; and mass spectrometric methods for mapping and sequence analysis. The impetus provided by the discovery of heparin contamination with oversulphated chondroitin sulphate has been influential in bringing combinations of many old and new techniques into use to ensure that heparin is sufficiently consistent and pure to be used safely. Synthetic and semi-synthetic heparins are in development and may become reality in the relatively near future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22566222     DOI: 10.1007/978-3-642-23056-1_5

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  6 in total

Review 1.  Glycosaminoglycanomics: where we are.

Authors:  Sylvie Ricard-Blum; Frédérique Lisacek
Journal:  Glycoconj J       Date:  2016-11-30       Impact factor: 2.916

2.  Complete Molecular Weight Profiling of Low-Molecular Weight Heparins Using Size Exclusion Chromatography-Ion Suppressor-High-Resolution Mass Spectrometry.

Authors:  Joseph Zaia; Kshitij Khatri; Joshua Klein; Chun Shao; Yuewei Sheng; Rosa Viner
Journal:  Anal Chem       Date:  2016-10-17       Impact factor: 6.986

3.  The US regulatory and pharmacopeia response to the global heparin contamination crisis.

Authors:  Anita Y Szajek; Edward Chess; Kristian Johansen; Gyöngyi Gratzl; Elaine Gray; David Keire; Robert J Linhardt; Jian Liu; Tina Morris; Barbara Mulloy; Moheb Nasr; Zachary Shriver; Pearle Torralba; Christian Viskov; Roger Williams; Janet Woodcock; Wesley Workman; Ali Al-Hakim
Journal:  Nat Biotechnol       Date:  2016-06-09       Impact factor: 54.908

Review 4.  Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition.

Authors:  Bridgette J Connell; Hugues Lortat-Jacob
Journal:  Front Immunol       Date:  2013-11-20       Impact factor: 7.561

Review 5.  Development and use of sulodexide in vascular diseases: implications for treatment.

Authors:  Sergio Coccheri; Ferdinando Mannello
Journal:  Drug Des Devel Ther       Date:  2013-12-24       Impact factor: 4.162

6.  Acetylcholine secretion by motor neuron-like cells from umbilical cord mesenchymal stem cells.

Authors:  Xueyuan Liu; Dehua Li; Dong Jiang; Yan Fang
Journal:  Neural Regen Res       Date:  2013-08-05       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.